Burjeel’s 11% ADX IPO put AED 3.35bn UAE hospital margins in public view

Burjeel Holdings planned an 11% listing on ADX, giving UAE hospital operators a public marker for a group with AED 3.351 billion in 2021 revenue.

The takeaway for healthcare executives was immediate: the filing put revenue, EBITDA, net profit, patient volume and dividend policy into a listed-market frame for one of the UAE’s largest private hospital groups.

What Burjeel offered investors

The Gulf Business report, dated 26 September 2022, said Burjeel Holdings intended to offer 550.729 million shares. The offer included 200.397 million new shares and up to 350.331 million existing shares sold by VPS Healthcare Holdings.

The subscription window was scheduled to open on 30 September 2022 and close on 4 October 2022. Trading was planned for 10 October 2022 on ADX. Burjeel allocated 10% of the offer to the first tranche and 90% to the second tranche, according to Gulf Business.

• 11% planned free float on ADX.
• 550.729 million total shares offered.
• AED 3.351 billion revenue for the year ended 31 December 2021.
• AED 234.1 million net profit in 2021.

Why the numbers matter for operators

Burjeel Holdings reported AED 779.1 million in 2021 EBITDA, which gave CFOs a public comparison point for margin analysis in UAE private hospitals. Its first-half 2022 figures showed AED 1.898 billion in revenue, AED 414.2 million in EBITDA and AED 152.9 million in net profit.

Burjeel Holdings said it treated 105,000 inpatients and 4.8 million outpatients in 2021. Its stated UAE private-market share was about 17% for inpatient admissions and 12% for outpatient volumes as at 30 June 2022. Those figures help CEOs and COOs compare bed use, outpatient conversion and specialty economics against a listed peer.

“As healthcare expenditure continues to increase across the region, Burjeel Holdings is strongly positioned to benefit.” Dr. Shamsheer Vayalil Parambath, chairman, Burjeel Holdings

The planned dividend policy also mattered. Burjeel Holdings said it intended to pay cash dividends from 2023, with an expected payout ratio of 40% to 70% of net income. For competing hospital groups, that ratio set investor expectations for growth capex, balance-sheet discipline and distributions.

Regulatory context to watch

Burjeel Holdings operated 61 assets at the time, including 39 hospitals and medical centres, pharmacies and allied services. Its brands included Burjeel, Medeor, LLH, Lifecare and Tajmeel. Abu Dhabi and Al Ain expansion sat under Department of Health Abu Dhabi facility licensing rules, Dubai assets required Dubai Health Authority approvals and Northern Emirates facilities fell under Ministry of Health and Prevention oversight.

That multi-emirate model carries real operating cost. A provider licensed by Department of Health Abu Dhabi, Dubai Health Authority and Ministry of Health and Prevention needs separate compliance processes, clinician credentialing workflows and payer relationships. Burjeel Holdings showed why smaller groups may need to specialise, sell assets or build referral partnerships.

The IPO followed International Holding Company’s acquisition of a 15% stake in Burjeel Holdings in September 2022. Burjeel Holdings had also signed an August 2022 memorandum of understanding with Saudi Arabia’s Ministry of Investment, covering potential investment of up to $1 billion in Saudi Arabia by 2030, according to Gulf Business.

For healthcare executives, the number to remember is 11%: a small float that still created a public yardstick for UAE hospital revenue scale, EBITDA conversion, dividend policy and cross-emirate operating complexity.